HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 45 filers reported holding HARPOON THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $205,046 | +26221.7% | 288,797 | -72.4% | 0.00% | – |
Q1 2023 | $779 | -13.2% | 1,046,523 | -15.3% | 0.00% | – |
Q4 2022 | $897 | -99.9% | 1,236,289 | +81.5% | 0.00% | – |
Q3 2022 | $661,000 | -40.3% | 681,172 | +17.5% | 0.00% | -100.0% |
Q2 2022 | $1,108,000 | +1144.9% | 579,919 | +3145.9% | 0.00% | – |
Q1 2022 | $89,000 | -88.4% | 17,866 | -82.4% | 0.00% | – |
Q4 2021 | $768,000 | -83.9% | 101,775 | -83.1% | 0.00% | -100.0% |
Q3 2021 | $4,762,000 | +261.0% | 602,752 | +534.1% | 0.00% | +200.0% |
Q2 2021 | $1,319,000 | -42.6% | 95,063 | -13.5% | 0.00% | 0.0% |
Q1 2021 | $2,299,000 | -23.6% | 109,917 | -39.3% | 0.00% | -50.0% |
Q4 2020 | $3,010,000 | -9.2% | 181,207 | -9.2% | 0.00% | -60.0% |
Q2 2020 | $3,315,000 | +249.3% | 199,673 | +143.7% | 0.01% | +150.0% |
Q1 2020 | $949,000 | -20.8% | 81,937 | +1.1% | 0.00% | +100.0% |
Q4 2019 | $1,198,000 | +478.7% | 81,020 | +408.7% | 0.00% | – |
Q2 2019 | $207,000 | -82.7% | 15,928 | -87.4% | 0.00% | -100.0% |
Q1 2019 | $1,199,000 | – | 126,656 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,156,699 | $2,290,816 | 1.66% |
MPM ASSET MANAGEMENT LLC | 3,131,388 | $2,273,388 | 0.95% |
MPM BioImpact LLC | 3,196,707 | $2,320,809 | 0.60% |
Telemetry Investments, L.L.C. | 93,000 | $67 | 0.11% |
Artal Group S.A. | 1,000,000 | $726 | 0.04% |
LEVIN CAPITAL STRATEGIES, L.P. | 330,000 | $239,481 | 0.03% |
Cormorant Asset Management, LP | 540,600 | $392 | 0.03% |
Orbimed Advisors | 1,516,496 | $1,100,521 | 0.02% |
Tekla Capital Management LLC | 259,910 | $188,617 | 0.01% |
KENNEDY CAPITAL MANAGEMENT LLC | 161,490 | $117,193 | 0.00% |